Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 2, 1999, Pages 129-137

  Maat Schieman, Marion L C ^a   Dorsman, Josephine C ^a   Smoor, Magda A ^a   Siesling, Sabine ^a   Van Duinen, Sjoerd G ^a   Verschuuren, Jan J G M ^a   Den Dunnen, Johan T ^a   Van Ommen, Gert Jan B ^a   Roos, Raymund A C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dystrophic neurites; Huntingtin; Huntington disease; Immunohistochemistry; Neuronal intranuclear inclusions; Ubiquitin

Indexed keywords

ANTISERUM; HUNTINGTIN; UBIQUITIN;

ADULT; AGED; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; CELL GRANULE; CELL INCLUSION; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DYSTROPHY; ENTORHINAL CORTEX; EPILEPSY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; HUNTINGTON CHOREA; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; MALE; NEOCORTEX; NEOSTRIATUM; NERVE CELL; NEURITE; OLFACTORY CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SUBICULUM;

EID: 0033025958     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199902000-00003     Document Type: Article

References (55)

1. Martin JB, Gusella JF. Huntington's disease: pathogenesis and management. N Engl J Med 1986;315:1267-76
2. Roos RAC. Neuropathology of Huntington's chorea. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of clinical neurology. Amsterdam, Elsevier, 1986;5:315-26
3. Robitaille Y, Lopes-Cendes I, Becher M, Rouleau G, Clark AW. The neuropathology of CAG repeat diseases: Review and update of genetic and molecular features. Brain Pathol 1997;7:901-26
4. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-83
5. Rubinzstein DC, Leggo J, Coles R, et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 1996;59:16-22
6. Sathasivam K, Amaechi I, Mangiarini L, Bates G. Identification of an HD patient with a (CAG)180 repeat expansion and the propagation of highly expanded CAG repeats in lambda phage. Hum Genet 1997;99:692-95
7. De Rooij KE, De Koning Gans PAM, Skraastad MI, et al. Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range. J Med Genet 1993;30:996-1002
8. Duyao M, Ambrose CM, Myers RM, et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet 1993;4:387-92
9. Snell RG, MacMillan JC, Cheadle JP, et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet 1993;4:393-97
10. Li S-H, Schilling G, Young WS, et al. Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron 1993; 11:985-93
11. Strong TV, Tagle DA, Valdes JM, et al. Widespread expression of the human and rat Huntington's disease gene in brain and nonneuronal tissues. Nat Genet 1993;5:259-65
12. Landwehrmeyer GB, McNeil SM, Dure LS, et al. Huntington's disease gene: Regional and cellular expression in brain of normal and affected individuals. Ann Neurol 1995;37:218-30
13. Hoogeveen AT, Willemsen R, Meyer N, de Rooij KE, Roos RAC, van Ommen G-J B, Galjaard H. Characterization and localization of the Huntington disease gene product. Hum Mol Genet 1993;2: 2069-73
14. DiFiglia M, Sapp E, Chase K, et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 1995;14:1075-81
15. Gutekunst C-A, Levey AI, Heilman CJ, et al. Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc Natl Acad Sci USA 1995;92:8710-14
16. Sharp AH, Loev SJ, Schilling G, et al. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 1995;14: 1065-74
17. Trottier Y, Devys D, Imbert G, et al. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat Genet 1995;10:104-10
18. Sapp E, Schwarz C, Chase K, et al. Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol 1997;42: 604-12
19. Bessert DA, Gutridge KL, Dunbar JC, Carlock LR. The identification of a functional nuclear localization signal in the Huntington disease protein. Mol Brain Res 1995;33:165-73
20. De Rooij KE, Dorsman JC, Smoor MA, Den Dunnen JT, Van Ommen G-JB. Subcellular localization of the Huntington's disease gene product in cell lines by immunofluorescence and biochemical subcellular fractionation. Hum Mol Genet 1996;5:1093-99
21. Aronin N, Chase K, Young C, et al. CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain. Neuron 1995;15:1193-1201
22. Schilling G, Sharp AH, Loev SJ, Wagster MV, Li S-H, Stine OC, Ross CA. Expression of the Huntington's disease (IT15) protein product in HD patients. Hum Mol Genet 1995;4:1365-71
23. Ross CA. Intranuclear neuronal inclusions: A common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 1997;19:1147-50
24. Davies SW, Turmaine M, Cozens BA, et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997;90:537-48
25. DiFiglia M, Sapp E, Chase KO, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neuntes in brain. Science 1997;277:1990-93
26. Paulson HL, Perez MK, Trottier Y, et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 1997;19:333-44
27. Skinner PJ, Koshy BT, Cummings CJ, et al. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 1997;389:971-74
28. Holmberg M, Duyckaerts C, Durr A, et al. Spinocerebellar ataxia type 7 (SCA7): A neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet 1998;7:913-18
29. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine 1992;71:59-72
30. Giometto B, Scaravilli T, Nicolao P, et al. Detection of paraneoplastic anti-neuronal autoantibodies on paraffin-embedded tissues. Acta Neuropathol 1996;92:435-40
31. Vonsattel J-P, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985;44:559-77
32. Yuen P, Baxter DW. The morphology of Marinesco bodies (paranucleolar corpuscles) in the melanin-pigmented nuclei of the brainstem. J Neurol Neurosurg Psychiat 1963;26:178-83
33. Leestma JE, Andrews JM. The fine structure of the Marinesco body. Arch Pathol 1969;88:131-36
34. Dickson DW, Wertkin A, Kress Y, Ksiezak-Reding H, Yen S-H. Ubiquitin immunoreactive structures in normal human brains. Lab Invest 1990;63:87-99
35. Cammarata S, Caponnetto C, Tabaton M. Ubiquitin-reactive neurites in cerebral cortex of subjects with Huntington's chorea: a pathological correlate of dementia? Neurosci lett 1993;156:96-98
36. Jackson M, Gentleman S, Lennox G, et al. The cortical neuritic pathology of Huntington's disease. Neuropathol Appl Neurobiol 1995;21:18-26
37. Tellez-Nagel I, Johnson AB, Terry RD, Ultrastructural and histochemical study of cerebral biopsies in Huntington's chorea. Adv Neurol 1973;1:387-98
38. Cudkowicz M, Kowall NW. Degeneration of pyramidal projection neurons in Huntington's disease cortex. Ann Neurol 1990;27:200-204
39. Hedreen JC, Peyser CE, Folstein SE, Ross CA. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett 1991;133:257-61
40. Macdonald V, Halliday GM, Trent RJ, McCuskcr EA. Significant loss of pyramidal neurons in the angular gyrus of patients with Huntington's disease. Neuropathol Appl Neurobiol 1997;23:492-95
41. Braak H, Braak E. Allocortical involvement in Huntington's disease. Neuropathol Appl Neurobiol 1992;18:539-47
42. Spargo E, Everall IP, Lantos PL. Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection. J Neurol Neurosurg Psychiat 1993;56:487-91
43. Byers RK, Gilles FH, Fung C. Huntington's disease in children. Neurology 1973;23:561-69
44. Mann DMA. Subcortical afferent projection systems in Huntington's chorea. Acta Neuropathol 1989;78:551-54
45. Oyanagi K, Takeda S, Takahashi H, Ohama E, Ikuta F. A quantitative investigation of the substantia nigra in Huntington's disease. Ann Neurol 1989;26:13-19
46. Rodda RA. Cerebellar atrophy in Huntington's disease. J Neurol Sci 1981;50:147-57
47. Ferrante RJ, Gutekunst C-A, Persichetti F, et al. Heterogeneous expression of huntingtin immunoreactivity in the normal human neostriatum. (Abstract) Neurology 1997;48:A202
48. Gourfinkel-An I, Cancel G, Trottier Y, et al. Differential distribution of the normal and mutated forms of huntingtin in the human brain. Ann Neurol 1997;42:712-19
49. Goldberg YP, Nicholson DW, Rasper DM, et al. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat Genet 1996;13:442-49
50. Dragunow M, Faull RL, Lawlor P, Beilharz EJ, Singleton K, Walker EB, Mee E. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 1995;6:1053-57
51. Dragunow M, Preston K. The role of inducible transcription factors in apoptotic nerve cell death. Brain Res Rev 1995;21:1-28
52. Protera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE. Evidence for apoptotic cell death in Huntington disease and exitotoxic animal models. J Neurosci 1995;15:3775-87
53. Smale G, Nichols NR, Brady DR, Finch CE, Horton WE Jr. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 1995;133:225-30
54. Thomas LB, Gates DJ, Richfield EK, O'Brien TF, Schweitzer JB, Steindler DA. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp Neurol 1995;133:265-72
55. Yang F, Sun X, Beech W, et al. Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am J Pathol 1998;152:379-89